FDA Considers Regulating CBD Products

MMP News AuthorJanuary 3, 2023
FDA officials are concerned about the safety of legal cannabis-infused foods and supplements and may recommend regulating the products later this year, according to a new report.  The products can have drug-like effects on the body and contain CBD (cannabidiol) and THC (tetrahydrocannabinol). Both CBD and THC can be derived ... Read More

Understanding CBD and its rising popularity in pain management

MMP News AuthorOctober 29, 2022
Host Eddie Celaya recently spoke with some of the country’s premier experts in Cannabidiol (better known as CBD). To help explain the science behind the cannabinoid that is seemingly everywhere, the episode’s first guest is Dr. John Streicher of the University of Arizona. Streicher is part of a team of pioneering researchers ... Read More

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

MMP News AuthorJuly 28, 2022
The coronavirus disease 2019 (COVID-19) pandemic, caused by the sudden outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has claimed more than 6.39 million lives worldwide. Scientists have worked extensively to develop pharmaceutical and non-pharmaceutical measures to protect individuals from COVID-19 infection. All the available COVID-19 vaccines have been designed ... Read More

The physiological relevance and effects of probable in vivo transformation of CBD to delta9-THC in humans

MMP News AuthorJune 10, 2022
In a recent review published in Cannabis and Cannabinoid Research, researchers reviewed studies on the probable conversion of orally administered cannabidiol (CBD) to delta9-tetrahydrocannabinol (delta9-THC or THC) in humans. Study: A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans. Image Credit: Yarygin/Shutterstock In vitro studies with ... Read More

Medical Marijuana, Inc. Subsidiary Kannaway(R) Enters CBN Market; Expands Cannabinoid Portfolio

MMP News AuthorOctober 29, 2020
Medical Marijuana, Inc. Subsidiary Kannaway(R) Enters CBN Market; Expands Cannabinoid Portfolio SAN DIEGO, CA, Oct 29, 2020 (GLOBE NEWSWIRE via COMTEX) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, ... Read More

Medical Marijuana, Inc. Subsidiary Kannaway® Enters CBN Market; Expands Cannabinoid Portfolio

MMP News AuthorOctober 29, 2020
/EIN News/ — SAN DIEGO, CA, Oct. 29, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has officially entered ... Read More